期刊文献+

细胞色素P450酶17基因多态性与迟发型男性性腺功能减退症的相关性研究 被引量:1

The association between polymorphism of CYP17 gene and late-onset male hypogonadism
下载PDF
导出
摘要 目的:探讨细胞色素P450酶17(CYP17)基因多态性与迟发型男性性腺功能减退症(LOH)的关系,研究LOH的发病机制。方法纳入年龄在49~79岁的中老年男性356例,其中36例诊断为迟发性性腺功能减退症患者,随机抽取130例正常健康中老年男性,测量身高、体质量、腰围(WC)、血压,测定三酰甘油(TG)、总胆固醇(TC)、空腹血糖(FBG)、血清总睾酮(T)、雌二醇(E2),并应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测CYP17基因多态位点的片段,产物在2%琼脂糖凝胶上电泳确定出CYP17基因型,比较两组各指标之间的差异。结果 CYP17基因呈多态性:A1/A1、A1/A2和A2/A2。正常健康中老年男性的SBP、BMI、TG、TC 和,FBG较 LOH 患者低(P<0.05),而 T和 T/E2比值较 LOH 组显著升高(P<0.01),两组间E2差异无统计学意义(P>0.05)。正常健康中老年男性组CYP17不同基因型之间T和T/E2比值差异无统计学意义(P>0.05);LOH组CYP17不同基因型之间T和T/E2比值差异有统计学意义(P<0.05),两组不同基因型之间E2差异无统计学意义(P>0.05)。LOH组较正常健康中老年男性组CYP17基因杂合变异型A1/A2呈现低频率分布(33.3%),而纯合变异型A2/A2呈高频率分布(47.3%),差异有统计学意义(P<0.05)。结论 CYP17基因多态性可能与LOH患者的T水平有关,低水平的T和T/E2比值可能是LOH发病的危险因素。 Objective To investigate the association between the polymorphisms in CYP17 gene with late-onset male hypogonadism (LOH)and explore the pathogenesis of LOH.Methods The investigation involved 356 men aged 40-79 years,including 36 cases with LOH.130 healthy middle-aged males were randomly selected.The body mass index (BMI),height,waist circumference (WC)and blood pressure were measured and the levels of Triglycer-ide (TG),serum total cholesterol (TC),fasting blood glucose (FBG),serum total testosterone(T),serum estradiol (E2 )were also detected.The polymorphisms of CYP17 gene were examined by PCR.Results The polymorphisms of CYP17 gene were A1/A1,A1/A2 and A2/A2.The mean SBP,BMI,TG,TC and FBG in the healthy males were sig-nificantly lower (P<0.05),whileT and T/E2ratio were markedly higher compared with the LOH males(P〈0.01), There was no significant difference in the level of E2 between the two groups(P〈0.05 ).There were no significant difference in the levels of serum T and T/E2 ratio of the different CYP17 genotypes in the normal middle-aged males (P〈0.05),while significant difference was found in the different CYP17 genotypes in LOH males (P〈0.05),and there was no significant difference in the level of E2 in the different CYP17 genotypes between the two groups(P〈;0.05).Heterozygous variants (A1/A2)of CYP17 were present in less frequency (33.3%)and homozygous (A2/A2)variants were higher frequently (47.3%)found in LOH,and the results were significant(P〈0.05).Conclu-sion Polymorphisms in CYP17 gene may be associated with serum T concentrations in LOH cases,and low levels of serum T and T/E2 ratio might possibly act as risk factors for LOH.
出处 《中国临床保健杂志》 CAS 2014年第2期141-144,共4页 Chinese Journal of Clinical Healthcare
基金 安徽省2008年度重点科研计划(08020303073) 安徽省科技计划项目(12010402134)
关键词 性腺功能减退症 类固醇17-α-羟化酶 多态性 单核苷酸 危险因素 Hypogonadism Steroid 17-alpha-Hydroxylase Polymorphism,Single Nucleotide Risk Factors
  • 相关文献

参考文献11

  • 1Jone KA, Kadonaga JT, Luciw PAL, et al. Activation of the AIDS retrovims promoter by the cellular transcription fac- tor, Sp1 [ J ]. Science, 1986,232 (4751 ) : 755 -759.
  • 2Carey AH, Waterworth D, Patel K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17 [ J]. Hum Mol Genet, 1994,3 (10) : 1873-1876.
  • 3Somner J, McLellan S, Cheung J, et al. Polymorphisms in the P450c17 ( 17-hydroxylase/17, 20-Lyase ) and P450c19 (aromatase) genes:association with serum sex steroid concentrations and bone mineral density in postm- enopausal women [ J ]. J Clin Endocrinol Metab, 2004,89 ( 1 ) :344-351.
  • 4Svartberg J. Epidemiology:testosterone and the metabolic syndrome [ J ]. Int J Impot Res,2007,19 (2) : 124-128.
  • 5Laaksonen DE, Niskanen L, Punnonen K, et al. The meta- bolic syndrome and smoking in relation to hypogonadism in middle aged men:A prospective cohort study [ J ]. J Clin Endocrinol Metab ,2005,90(2) :712-719.
  • 6Svartberg J, van Muhlen D, Schirmer H, et al. Association of endogenous testosterone with blood pressure and left ventricular mass in men. the troms 6 study [ J ]. Eur J En- docrino1,2004 ,150 ( 1 ) : 65-71.
  • 7Vermeulen A, Goemaere S, Kaufman JM, et al. Sex hor- mones, body composition and aging [ J ]. The Aging Male, 2003,2(1) :8-16.
  • 8Ferrari P, Bianchetti M, Frey FJ. Juvenile hypertension, the role of genetically altered steroid metabolism [ J ]. Horm Res ,2001,55 (5) :213-223.
  • 9罗松涛,王应洪,李绪鲲,柯井卫,唐义权.细胞色素P450酶17基因T-34C多态性与前列腺癌易感性关系的Meta分析[J].中国全科医学,2012,15(35):4097-4100. 被引量:2
  • 10Allen NE, Forrest MS, Key TJ. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men[ J ]. Cancer Epidemiol Biomarkers Prey, 2001,10 (3) :185-189.

二级参考文献23

  • 1王军起,古力米热,李鸿伟,刘建河,佟明,艾军魁,袁亦铭,辛殿祺,李鸣,那彦群.中国汉族男性CYP17基因多态性与前列腺癌发生危险性的关系[J].中华泌尿外科杂志,2004,25(8):512-515. 被引量:4
  • 2Jemal A,Siegel R,Ward E,et al. Cancer statistics,2009 [ J]. CACancer J Clin, 2009,59 (4) : 225 -249.
  • 3Severi G, Hayes VM, Tesoriero AA, et al. The rs743572 common va-riant in the promoter of CYP17A1 is not associated with prostate cancerrisk or circulating hormonal levels [ J ]. BJU Int, 2008 , 101 ( 4 ):492 -496.
  • 4Cussenot 0,Azzouzi AR, Nicolaiew N, et al. Combination of poly-morphisms from genes related to estrogen metabolism and risk of prostatecancers: the hidden face of estrogens [ J]. J Clin Oncol,2007,25(24): 3596 - 3602.
  • 5Yang J, Wu HF, Zhang W, et al. Polymorphisms of metabolic enzymegenes,living habits and prostate cancer susceptibility [ J]. Front Bios-ci, 2006, 11 (20) : 52 -60.
  • 6Okugi H, Nakazato H, Matsui H, et al. Association of the polymor-phisms of genes involved in androgen metabolism and signaling pathways-with familial prostate cancer risk in a Japanese population [ J]. CancerDetect Prev, 2006, 30 (3) : 262 -268.
  • 7Forrest MS, Edwards SM, Houlston R, et al. Association betweenhormonal genetic polymorphisms and early - onset prostate cancer [ J ].Prostate Cancer Prostatic Dis, 2005,8 ( 1 ) : 95-102.
  • 8Vesovic Z, Herkomraer K, Vogel W, et al. Role of a CYP17 promoterpolymorphism for familial prostate cancer risk in Germany [ J ]. Anti-cancer Res, 2005, 25 (2B) : 303 -307.
  • 9Antognelli C, Mearini L, Talesa VN, et al. Association of CYP17,GSTP1, and PON1 polymorphisms with the risk of prostate cancer [ J].Prostate, 2005,63 (3) : 240 -251.
  • 10Madigan MP, Gao YT, Deng J, et al. CYP17 polymorphisms in rela-tion to risks of prostate cancer and benign prostatic hyperplasia : a pop-ulation -based study in China [J]. Int J Cancer, 2003 , 107 (2):271 -275.

共引文献1

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部